Postoperative adult respiratory distress syndrome as a possible consequence of bleomycin therapy performed 7 years ago: A case study;Postoperatives adult respiratory distress syndrome als mögliche folge einer sieben jahre zurückliegenden bleomycintherapie - Ein fallbericht

Anasthesiologie und Intensivmedizin

Volumn 44, Issue 6, 2003, Pages 436-440

  Schaaf, Wolfgang ^a   Vogel, H ^a   Kreuser, E ^a   Demand, M ^a  

^a NONE

Author keywords

Adult Respiratory Distress Syndrome (ARDS); Bleomycin; Chemotherapy; Cytostatics; Oxygen

Indexed keywords

BLEOMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FENTANYL; ORAL CONTRACEPTIVE AGENT; PROCARBAZINE; PROPOFOL; SUXAMETHONIUM; VECURONIUM; VINBLASTINE; VINCRISTINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; ARTICLE; CASE REPORT; CHEMOTHERAPY; CHOLECYSTECTOMY; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; EVALUATION; FEMALE; FLUID THERAPY; HODGKIN DISEASE; HUMAN; OXYGEN THERAPY; POSTOPERATIVE PERIOD; REVIEW; SCREENING TEST; TREATMENT OUTCOME;

EID: 0038573534     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bernard GR, Artigas A, Brigham KL; The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Medicine 1994 Vol 149:818-24
2. Blum RH, Carter SK, Agree KA; A clinical review of bleomycin. Cancer 73 Vol 31:904-914
3. Burger R-M, Peisach J, Horwitz S-B; Mechanism of bleomycin action: In vitro studies. Life Sci Vol 28:715-727
4. Cersosimo RJ, Matthews SJ, Hong WK; Bleomycin pneumonitis potentiated by oxygen administation. Drug Intell Clin Pharm 1985 Vol 19:921-23
5. Comis RL; Bleomycin toxicity. In:Carter SK, Umezawa H. Bleomycin: current status and new development. New York: Academic Press Inc. 1978:279-81
6. Conley NS, Yarbro JW, Ferrari HA, Zeitler RB: Bleomycin increases superoxidation generation by pig alveolar macrophages. Mol Pharmacol 1986 Vol 30:48-52
7. Cooper J jr., White DA, Matthay RA; Drug-induced pulmonary disease. Am Rev Resp Dis 86 Vol 133:321-340
8. Cutroneo KR, Sterling KM jr; The biochemical and molecular basis of bleomycin-induced pulmonary fibrosis. Focus Pulmon Pharmacol Toxicol 1988 Vol 1:1-22
9. Donohue JP, Rowland RG; Complication of retroperitoneal lymph node dissection. J Urol 1981 Vol 125:338-40
10. Douglas M-J, Coppin C-M-L; Bleomycin and subsequent anesthesia: a retrospective study at Vancouver General Hospital Can. Anaesth Soc J 80 Vol:27:449-52
11. Einhorn LH, Williams SD, Mandelbaum I, Donohue JP; Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 81 Vol 48:904-908
12. Goldiner P-L, Carlon C-C, Cvitkovic E, Schweizer O, Holland W-S; Factors influencing postoperative morbidity and mortality in patients treated with bleomycin. BMJ 78 Vol 1:1664-67
13. Gilson AJ, Sahn SH; Reactivation of bleomycin lung toxicity following oxygen administration. Chest 85 Vol 88:304-306
14. Gutteridge J-M, Quinlan-G-J, Evans-T-W; Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory distress syndrome. Thorax 1994 Vol 49:707-10
15. Haels J, Weidauer H, Krier C. Perioperative respiratorische Probleme Bleomycin-vorbehandelter Patienten. Laryng Rhinol Otol 86, Vol 65:226-229
16. Ingrassia T-S, Ryu J-H, Trastek V-F, Rosenow E-C; Dosis Oxygen exacerbated bleomycin pulmonary toxicity; Mayo Clin Proc 91, Vol 66:173-78
17. La Mantia K-R, Glick J-H, Marshall E-B; Supplemental oxygen does not cause respiratory failure in bleomycin - treated patients. Anesthesiology 84, Vol 60:65-67
18. Lehne G.,Lote K. Pulmonary toxicity ofcytotoxic and immunosuppressive agents: a review. Acta Oncol 90 Vol 29:113ff
19. Lower EE; Strohhofer S, Baughman RP; Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide; Am J Med Sci 1988 Vol 295:193-97
20. Madline I, Waid-Jones MD, Coursin B; Perioperative considerations for patients treated with bleomycin. Chest 1991 Vol 99:993-99
21. Parvin LM, Kikku P, Makinen E, Liukko P, Gronroos M; Factors affecting the pulmonary toxicity of bleomycin. Acta Radiol 1983 Vol 22:417-21
22. Produktinformation Bleomycin Mack®
23. Roizen M-F; Anesthetic implications of concurrent diseases. Anesthesia Ronald D. Miller 90 S:865
24. Strickland R-A, Spackman T-N, Wedel J-D; Anesthetic management of bleomycin-treated patients. Mayo Clin Proc 91, Vol 66:548
25. Samuel J, Kassow RT, Goodson M, Seikh M, Lumb P; Aaesthesiol. Management of myocardial revascularisation following bleomycin chemotherapy. J Cardiothor Vasc Anesth 1991 Vol 5:379-81
26. Schütte J., Niederle N, Seeber S., Schmidt C.G; Die Bleomycinpneumonitis. Untersuchungen zur Häufigkeit, Differenzialdiagnose und Verlauf bei Patienten mit nicht seminomatösen Hodentumoren. Tumordiagnostik und Therapie 1983, Vol 4:114-21
27. Scheulen ME; Reduction of pulmonary toxicity. Cancer Treat Rev 1987 Vol 14:231-43
28. Ware LB, Mattay MA; The Acute Respiratory Distress Syndrome. N Engl J Med 2000;342:1334-49
29. Yamauchi T, Raffin TA, Yang P, Sikik BI; Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin. Cancer Chemother Pharmacol 1987, Vol 19:282-86.